Document:

Exhibit 10.4

 

FORM OF SUBSCRIPTION AGREEMENT

 

LabStyle Innovations Corp.

350 Fifth Avenue, 59th Floor

New York, NY 10018

 

Ladies and Gentlemen:

 

1.            Subscription.
The undersigned (the “Purchaser”), intending to be legally bound, hereby irrevocably agrees to purchase from LabStyle
Innovations Corp., a Delaware corporation (the “Company”) the number of units (the “Units”) set forth on
the signature page hereof at a purchase price of $50,000 per Unit. Each Unit consists of (i) 50,000 shares of common stock, par
value $0.0001 per share, of the Company (the “Common Stock”), and (ii) warrants to purchase 50,000 shares of Common
Stock (the “Common Stock”) for a five year period at an initial exercise price of $1.50 per share (each a “Warrant”
and collectively, the “Warrants”). This subscription is submitted to you in accordance with and subject to the terms
and conditions described in this Subscription Agreement and the Confidential Information Memorandum of the Company dated September
1, 2011, as amended or supplemented from time to time, including all attachments, schedules and exhibits thereto (the “Memorandum”),
relating to the offering (the “Offering”) by the Company of a minimum of ten (10) Units ($500,000) (the “Minimum
Amount”) and a maximum of forty (40) Units ($2,000,000) (the “Maximum Amount”). The Units are being offered by
the Company on an exclusive basis through Spencer Trask Ventures, Inc. (the “Placement Agent”) on a “reasonable
efforts, all or none” basis with respect to the Minimum Amount and on a “reasonable efforts” basis with respect
to all Units in excess of the Minimum Amount.” The minimum purchase is one Unit ($50,000), although the Company and the Placement
Agent may, in their discretion, accept subscriptions for a lesser number of Units. The Company and the Placement Agent may elect
to increase the Maximum Amount and sell up to an additional twenty (20) Units ($1,000,000).

 

The terms of the Offering
are more completely described in the Memorandum and such terms are incorporated herein in their entirety.

 

2.         
  Payment. The Purchaser encloses herewith a check payable to, or will immediately
make a wire transfer payment to, “Signature Bank, Escrow Agent for LabStyle Innovations Corp.” in the full amount
of the purchase price of the Units being subscribed for. Wire transfer instructions are set forth on page 12 hereof under the
heading “To subscribe for Units in the private offering of LabStyle Innovations Corp.” Such funds will be held for
the Purchaser's benefit, and will be returned promptly, without interest or offset if this Subscription Agreement is not accepted
by the Company, the Offering is terminated pursuant to its terms by the Company or the Placement Agent prior to the First Closing
(as hereinafter defined), or the Minimum Amount is not sold. Together with a check for, or wire transfer of, the full purchase
price, the Purchaser is delivering a completed and executed Omnibus Signature Pages to this Subscription Agreement and the Investor
Rights Agreement, in the form of Annex B to the Memorandum (the “Investor Rights Agreement”).

 

    	 

    	 

    

 

3.         
  Deposit of Funds. All payments made as provided in Section 2 hereof shall be deposited by the
Company or the Placement Agent as soon as practicable after receipt thereof with Signature Bank (the “Escrow
Agent”), in a non-interest-bearing escrow account (the “Escrow Account”) until the earliest to occur of (a)
the closing of the sale of the Units being purchased pursuant to this Subscription Agreement in accordance with the Offering
terms, (b) the rejection of such subscription and (c) the termination of the Offering by the Company or the Placement Agent.
The Company and the Placement Agent may continue to offer and sell the Units and conduct additional closings for the sale of
additional Units after the initial closing (“First Closing”) and until the termination of the Offering. In the
event that the Company does not effect a closing, on or before October 31, 2011 (the “Initial Offering Period”),
which period may be extended by the Company and the Placement Agent, in their mutual discretion to a date no later than
December 30, 2011 (the “Termination Date”, with this additional period, together with the Initial
Offering Period, being referred to herein as the “Offering Period”), the Company will refund all subscription
funds, without deduction and/or interest accrued thereon, and will return the subscription documents to each Purchaser. If
the Company and/or the Placement Agent rejects a subscription, either in whole or in part (which decision is in their sole
discretion), the rejected subscription funds or the rejected portion thereof will be returned promptly to such Purchaser
without interest accrued thereon. 

 

4.     
      Acceptance of Subscription. The Purchaser understands and agrees that the
Company, in its sole discretion, reserves the right to accept or reject this or any other subscription for Units, in whole or
in part, notwithstanding prior receipt by the Purchaser of notice of acceptance of this subscription. The Company shall have
no obligation hereunder until the Company shall execute and deliver to the Purchaser an executed copy of this Subscription
Agreement. If this subscription is rejected in whole, the Offering is terminated, or the Minimum Amount is not sold within
the Offering Period, all funds received from the Purchaser will be returned without interest or offset, and this Subscription
Agreement shall thereafter be of no further force or effect. If this subscription is rejected in part, the funds for the
rejected portion of this subscription will be returned without interest or offset, and this Subscription Agreement will
continue in full force and effect to the extent this subscription was accepted.

 

5.            Representations
and Warranties.

 

The Purchaser hereby
acknowledges, represents, warrants, and agrees as follows:

 

(a)          None
of the securities comprising the Units, or the shares of common stock issuable upon exercise of the Warrants (the “Warrant
Shares”) offered pursuant to the Memorandum are registered under the Securities Act of 1933, as amended (the “Securities
Act”), or any state securities laws. The Purchaser understands that the offering and sale of the Units is intended to be
exempt from registration under the Securities Act, by virtue of Section 4(2) thereof and the provisions of Regulation D promulgated
thereunder (“Regulation D”), based, in part, upon the representations, warranties and agreements of the Purchaser contained
in this Subscription Agreement;

 

(b)          Prior
to the execution of this Subscription Agreement, the Purchaser and the Purchaser's attorney, accountant, purchaser representative
and/or tax adviser, if any (collectively, the “Advisers”), have received the Memorandum and all other documents requested
by the Purchaser, have carefully reviewed them and understand the information contained therein;

 

(c)          Neither
the Securities and Exchange Commission nor any state securities commission or other regulatory authority has approved the Units,
the Common Stock, the Warrants, or the Warrant Shares, or passed upon or endorsed the merits of the offering of Units, or confirmed
the accuracy or determined the adequacy of the Memorandum. The Memorandum has not been reviewed by any federal, state or other
regulatory authority;

 

    	2

    	 

    

 

(d)          All
documents, records, and books pertaining to the investment in the Units (including, without limitation, the Memorandum) have been
made available for inspection by such Purchaser and its Advisers, if any;

 

(e)          The
Purchaser and its Advisers, if any, have had a reasonable opportunity to ask questions of and receive answers from a person or
persons acting on behalf of the Company concerning the offering of the Units, the business and financial condition of the Company,
and all such questions have been answered to the full satisfaction of the Purchaser and its Advisers, if any;

 

(f)          In
evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation or information
(oral or written) other than as stated in the Memorandum.

 

(g)          The
Purchaser is unaware of, is in no way relying on, and did not become aware of the Offering of the Units through or as a result
of, any form of general solicitation or general advertising including, without limitation, any article, notice, advertisement or
other communication published in any newspaper, magazine or similar media or broadcast over television, radio or the Internet (including,
without limitation, internet “blogs,” bulletin boards, discussion groups and social networking sites) in connection
with the Offering and sale of the Units and is not subscribing for the Units and did not become aware of the Offering of the Units
through or as a result of any seminar or meeting to which the Purchaser was invited by, or any solicitation of a subscription by,
a person not previously known to the Purchaser in connection with investments in securities generally;

 

(h)          The
Purchaser has taken no action that would give rise to any claim by any person for brokerage commissions, finders' fees or the like
relating to this Subscription Agreement or the transactions contemplated hereby (other than commissions to be paid by the Company
to the Placement Agent or as otherwise described in the Memorandum) and, in turn, to be paid to its selected dealers;

 

(i)          The
Purchaser, together with its Advisers, if any, has such knowledge and experience in financial, tax, and business matters, and,
in particular, investments in securities, so as to enable it to utilize the information made available to it in connection with
the Offering to evaluate the merits and risks of an investment in the Units and the Company and to make an informed investment
decision with respect thereto;

 

(j)          The
Purchaser is not relying on the Company, the Placement Agent or any of their respective employees or agents with respect to the
legal, tax, economic and related considerations of an investment in the Units, and the Purchaser has relied on the advice of, or
has consulted with, only its own Advisers;

 

(k)          The
Purchaser is acquiring the Units solely for such Purchaser's own account for investment purposes only and not with a view to or
intent of resale or distribution thereof, in whole or in part. The Purchaser has no agreement or arrangement, formal or informal,
with any person to sell or transfer all or any part of the Units, the Common Stock, the Warrants, the Warrant Shares, and the Purchaser
has no plans to enter into any such agreement or arrangement;

 

(l)          The
Purchaser must bear the substantial economic risks of the investment in the Units indefinitely because none of the securities
included in the Units may be sold, hypothecated or otherwise disposed of unless subsequently registered under the Securities Act
and applicable state securities laws or an exemption from such registration is available. Legends to
the following effect shall be placed on the securities included in the Units to the effect that they have not been registered
under the Securities Act or applicable state securities laws. Appropriate notations
will be made in the Company's stock books to the effect that the securities
included in the Units have not been registered under the Securities Act or applicable state securities laws. Stop transfer
instructions will be placed with the transfer agent, if any, of the Units. The Company has agreed that purchasers of the Units
will have the registration rights described in the Investor Rights Agreement. Notwithstanding such registration rights, there
can be no assurance that there will be any market for resale of the Units, the Common Stock, the Warrants, or the Warrant Shares
nor can there be any assurance that such securities will be freely transferable at any time in the foreseeable future;

 

    	3

    	 

    

 

(m)          The
Purchaser has adequate means of providing for such Purchaser's current financial needs and foreseeable contingencies and has no
need for liquidity of its investment in the Units for an indefinite period of time;

 

(n)          The
Purchaser is aware that an investment in the Units is high risk, involving a number of very significant risks and has carefully
read and considered the matters set forth under the caption “Risk Factors” in the Memorandum, and, in particular, acknowledges
that the Company is a start-up company in a highly competitive business with limited assets, no operations and no revenues to date;

 

(o)          The
Purchaser meets the requirements of at least one of the suitability standards for an “accredited investor” as that
term is defined in Regulation D and as set forth on the Accredited Investor Certification contained herein; or

 

(p)          The
Purchaser (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power and authority to
execute and deliver this Subscription Agreement and all other related agreements or certificates and to carry out the provisions
hereof and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock
company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific purpose
of acquiring the Units, such entity is duly organized, validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of
state law or its charter or other organizational documents, such entity has full power and authority to execute and deliver this
Subscription Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof and
to purchase and hold the securities constituting the Units, the execution and delivery of this Subscription Agreement has been
duly authorized by all necessary action, this Subscription Agreement has been duly executed and delivered on behalf of such entity
and is a legal, valid and binding obligation of such entity; or (iii) if executing this Subscription Agreement in a representative
or fiduciary capacity, represents that it has full power and authority to execute and deliver this Subscription Agreement in such
capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation, or limited liability company
or partnership, or other entity for whom the Purchaser is executing this Subscription Agreement, and such individual, partnership,
ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full right and power to perform
pursuant to this Subscription Agreement and make an investment in the Company, and represents that this Subscription Agreement
constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this Subscription Agreement will
not violate or be in conflict with any order, judgment, injunction, agreement or controlling document to which the Purchaser is
a party or by which it is bound;

 

(q)          The
Purchaser and the Advisers, if any, have had the opportunity to obtain any additional information, to the extent the Company had
such information in its possession or could acquire it without unreasonable effort or expense, necessary to verify the accuracy
of the information contained in the Memorandum and all documents received or reviewed in connection with the purchase of the Units
and have had the opportunity to have representatives of the Company provide them with such additional information regarding the
terms and conditions of this particular investment and the financial condition, results of operations, business of the Company
deemed relevant by the Purchaser or the Advisers, if any, and all such requested information, to the extent the Company had such
information in its possession or could acquire it without unreasonable effort or expense, has been provided to the full satisfaction
of the Purchaser and the Advisers, if any;

 

    	4

    	 

    

 

(r)          Any
information which the Purchaser has heretofore furnished or is furnishing herewith to the Company or the Placement Agent is complete
and accurate and may be relied upon by the Company and the Placement Agent in determining the availability of an exemption from
registration under federal and state securities laws in connection with the offering of securities as described in the Memorandum.
The Purchaser further represents and warrants that it will notify and supply corrective information to the Company and the Placement
Agent immediately upon the occurrence of any change therein occurring prior to the Company's issuance of the securities contained
in the Units;

 

(s)          The
Purchaser has significant prior investment experience, including investment in non-listed and non-registered securities. The Purchaser
is knowledgeable about investment considerations in development-stage companies. The Purchaser has a sufficient net worth to sustain
a loss of its entire investment in the Company in the event such a loss should occur. The Purchaser's overall commitment to investments
which are not readily marketable is not excessive in view of the Purchaser’s net worth and financial circumstances and the
purchase of the Units will not cause such commitment to become excessive. The investment is a suitable one for the Purchaser;

 

(t)          The
Purchaser is satisfied that the Purchaser has received adequate information with respect to all matters which it or the Advisers,
if any, consider material to its decision to make this investment;

 

(u)          The
Purchaser acknowledges that any estimates or forward-looking statements or projections included in the Memorandum were prepared
by the Company in good faith but that the attainment of any such projections, estimates or forward-looking statements cannot be
guaranteed by the Company and should not be relied upon;

 

(v)          No
oral or written representations have been made, or oral or written information furnished, to the Purchaser or the Advisers, if
any, in connection with the Offering which are in any way inconsistent with the information contained in the Memorandum;

 

(w)          Within
five (5) days after receipt of a request from the Company or the Placement Agent, the Purchaser will provide such information and
deliver such documents as may reasonably be necessary to comply with any and all laws and ordinances to which the Company or the
Placement Agent is subject;

 

(x)          The
Purchaser's substantive relationship with the Placement Agent or subagent through which the Purchaser is subscribing for Units
predates the Placement Agent's or such subagent's contact with the Purchaser regarding an investment in the Units;

 

(y)          THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND
ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID ACT
AND SUCH LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES
PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF THE MEMORANDUM OR THIS SUBSCRIPTION AGREEMENT.
ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL;

 

    	5

    	 

    

 

(z)          The
Purchaser acknowledges that none of the Units, the Common Stock, the Warrants, or the Warrant Shares have been recommended by any
federal or state securities commission or regulatory authority. In making an investment decision investors must rely on their own
examination of the Company and the terms of the Offering, including the merits and risks involved. Furthermore, the foregoing authorities
have not confirmed the accuracy or determined the adequacy of this Subscription Agreement or the Memorandum. Any representation
to the contrary is a criminal offense. The Units, the Common Stock, the Warrants, and the Warrant Shares are subject to restrictions
on transferability and resale and may not be transferred or resold except as permitted under the Securities Act, and the applicable
state securities laws, pursuant to registration or exemption therefrom. The Purchaser should be aware that it will be required
to bear the financial risks of this investment for an indefinite period of time;

 

(aa)         (For
ERISA plans only) The fiduciary of the ERISA plan (the “Plan”) represents that such fiduciary has been informed
of and understands the Company’s investment objectives, policies and strategies, and that the decision to invest “plan
assets” (as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification
of plan assets and impose other fiduciary responsibilities. The Purchaser fiduciary or Plan (a) is responsible for the decision
to invest in the Company; (b) is independent of the Company or any of its affiliates; (c) is qualified to make such investment
decision; and (d) in making such decision, the Purchaser fiduciary or Plan has not relied primarily on any advice or recommendation
of the Company or any of its affiliates;

 

(bb)         The
Purchaser should check the Office of Foreign Assets Control (“OFAC”) website at <http://www.treas.gov/ofac>
before making the following representations. The Purchaser represents that the amounts invested by it in the Company in the
Offering were not and are not directly or indirectly derived from activities that contravene federal, state or international laws
and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by
OFAC prohibit, among other things, the engagement in transactions with, and the provision of services to, certain foreign countries,
territories, entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found
on the OFAC website at <http://www.treas.gov/ofac>. In addition, the programs administered by OFAC (the “OFAC Programs”)
prohibit dealing with individuals1 or entities in certain countries regardless of whether such individuals or entities
appear on the OFAC lists;

 

(cc)         To
the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a country, territory, individual or entity
named on an OFAC list, or a person or entity prohibited under the OFAC Programs. Please be advised that the Company may not accept
any amounts from a prospective investor if such prospective investor cannot make the representation set forth in the preceding
paragraph. The Purchaser agrees to promptly notify the Company and the Placement Agent should the Purchaser become aware of any
change in the information set forth in these representations. The Purchaser understands and acknowledges that, by law, the Company
may be obligated to “freeze the account” of the Purchaser, either by prohibiting additional subscriptions from the
Purchaser, declining any redemption requests and/or segregating the assets in the account in compliance with governmental regulations,
and the Placement Agent may also be required to report such action and to disclose the Purchaser’s identity to OFAC. The
Purchaser further acknowledges that the Company may, by written notice to the Purchaser, suspend the redemption rights, if any,
of the Purchaser if the Company reasonably deems it necessary to do so to comply with anti-money laundering regulations applicable
to the Company and the Placement Agent or any of the Company’s other service providers. These individuals include specially
designated nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs;

 

 

1          These
individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject to OFAC
sanctions and embargo programs.

 

    	6

    	 

    

 

(dd)         To
the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a senior foreign political figure,2
or any immediate family3 member or close associate4 of a senior foreign political figure, as such
terms are defined in the footnotes below; and

 

(ee)         If
the Purchaser is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Purchaser receives deposits
from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Purchaser represents
and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country
in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related
to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank
to conduct banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does not
have a physical presence in any country and that is not a regulated affiliate.

 

6.          Indemnification.
The Purchaser agrees to indemnify and hold harmless the Company, the Placement Agent, and their respective officers, directors,
employees, agents, control persons and affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses
whatsoever (including, but not limited to, any and all expenses incurred in investigating, preparing or defending against any litigation
commenced or threatened) based upon or arising out of any actual or alleged false acknowledgment, representation or warranty, or
misrepresentation or omission to state a material fact, or breach by the Purchaser of any covenant or agreement made by the Purchaser
herein or in any other document delivered in connection with this Subscription Agreement.

 

7.          Irrevocability;
Binding Effect. The Purchaser hereby acknowledges and agrees that the subscription hereunder is irrevocable by the Purchaser,
except as required by applicable law, and that this Subscription Agreement shall survive the death or disability of the Purchaser
and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators, successors, legal
representatives, and permitted assigns. If the Purchaser is more than one person, the obligations of the Purchaser hereunder shall
be joint and several and the agreements, representations, warranties, and acknowledgments herein shall be deemed to be made by
and be binding upon each such person and such person's heirs, executors, administrators, successors, legal representatives, and
permitted assigns.

 

 

2  A
“senior foreign political figure” is defined as a senior official in the executive, legislative, administrative, military
or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political party, or
a senior executive of a foreign government-owned corporation. In addition, a “senior foreign political figure” includes
any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political figure.

 

3  “Immediate
family” of a senior foreign political figure typically includes the figure’s parents, siblings, spouse, children and
in-laws.

 

4  A “close associate”
of a senior foreign political figure is a person who is widely and publicly known to maintain an unusually close relationship with
the senior foreign political figure, and includes a person who is in a position to conduct substantial domestic and international
financial transactions on behalf of the senior foreign political figure.

 

    	7

    	 

    

 

8.          Modification.
This Subscription Agreement shall not be modified or waived except by an instrument in writing signed by the party against whom
any such modification or waiver is sought.

 

9.          Immaterial
Modifications to the Transaction Documents. The Company may, at any time prior to the First Closing, modify the Warrant in
the form of Annex C to the Memorandum and the Investor Rights Agreement (the Warrant and the Investor Rights Agreement are
collectively referred to herein as the “Transaction Documents”) if necessary to clarify any provision therein, without
first providing notice or obtaining prior consent of the Subscriber, if, and only if, such modification is not material in any
respect.

 

10.         Notices.
Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be mailed by certified
mail, return receipt requested, or delivered by facsimile transmission, or delivered against receipt to the party to whom it is
to be given (a) if to the Company, at the address set forth above, or (b) if to the Purchaser, at the address set forth on the
signature page hereof (or, in either case, to such other address as the party shall have furnished in writing in accordance with
the provisions of this Section 10). Any notice or other communication given by certified mail shall be deemed given at the time
of certification thereof, except for a notice changing a party's address which shall be deemed given at the time of receipt thereof.

 

11.         Assignability.
This Subscription Agreement and the rights, interests and obligations hereunder are not transferable or assignable by the Purchaser
and the transfer or assignment of the shares of Common Stock, the Warrants or the Warrant Shares shall be made only in accordance
with all applicable laws.

 

12.         Applicable
Law. This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable
to contracts to be wholly-performed within said State, and without regard to the conflicts of laws principles thereof.

 

13.         Arbitration.
The parties agree to submit all controversies to arbitration in accordance with the provisions set forth below and understand that:

 

(a)          Arbitration
is final and binding on the parties.

 

(b)          The
parties are waiving their right to seek remedies in court, including the right to a jury trial.

 

(c)          Pre-arbitration
discovery is generally more limited and different from court proceedings.

 

(d)          The
arbitrator's award is not required to include factual findings or legal reasoning and any party's right to appeal or to seek modification
of rulings by arbitrators is strictly limited.

 

(e)          The
panel of arbitrators will typically include a minority of arbitrators who were or are affiliated with the securities industry.

 

(f)          All
controversies which may arise between the parties concerning this Subscription Agreement shall be determined by arbitration pursuant
to the rules then pertaining to the Financial Industry Regulatory Authority, Inc. (“FINRA”) in New York City, New York.
The arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. Sec.1-16, and the judgment upon the award rendered by
the arbitrators may be entered by any court having jurisdiction thereof.  Any notice of such arbitration or for the confirmation
of any award in any arbitration shall be sufficient if given in accordance with the provisions of this Agreement. The parties agree
that the determination of the arbitrators shall be binding and conclusive upon them.

 

    	8

    	 

    

 

14.         Blue
Sky Qualification. The purchase of Units under this Subscription Agreement is expressly conditioned upon the exemption from
qualification of the offer and sale of the Units from applicable federal and state securities laws. The Company shall not be required
to qualify this transaction under the securities laws of any jurisdiction and, should qualification be necessary, the Company shall
be released from any and all obligations to maintain its offer, and may rescind any sale contracted, in the jurisdiction.

 

15.         Use
of Pronouns. All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, neuter,
singular or plural as the identity of the person or persons referred to may require.

 

16.         Confidentiality.
The Purchaser acknowledges and agrees that any information or data the Purchaser has acquired from or about the Company, not otherwise
properly in the public domain, was received in confidence. The Purchaser agrees not to divulge, communicate or disclose, except
as may be required by law or for the performance of this Agreement, or use to the detriment of the Company or for the benefit of
any other person or persons, or misuse in any way, any confidential information of the Company, including any scientific, technical,
trade or business secrets of the Company and any scientific, technical, trade or business materials that are treated by the Company
as confidential or proprietary, including, but not limited to, ideas, discoveries, inventions, developments and improvements belonging
to the Company and confidential information obtained by or given to the Company about or belonging to third parties.

 

17.         Miscellaneous.

 

(a)          This
Subscription Agreement, together with the Transaction Documents (which are to be issued or executed at closing), constitute the
entire agreement between the Purchaser and the Company with respect to the subject matter hereof and supersede all prior oral or
written agreements and understandings, if any, relating to the subject matter hereof. The terms and provisions of this Subscription
Agreement may be waived, or consent for the departure therefrom granted, only by a written document executed by the party entitled
to the benefits of such terms or provisions.

 

(b)          The
representations and warranties of the Company and the Purchaser made in this Subscription Agreement shall survive the execution
and delivery hereof and delivery of the securities contained in the Units.

 

(c)          Each
of the parties hereto shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others
engaged by such party) in connection with this Subscription Agreement and the transactions contemplated hereby whether or not the
transactions contemplated hereby are consummated.

 

(d)          This
Subscription Agreement may be executed in one or more counterparts each of which shall be deemed an original (including signatures
sent by facsimile transmission or by email transmission of a PDF scanned document), but all of which shall together constitute
one and the same instrument.

 

(e)          Each
provision of this Subscription Agreement shall be considered separable and, if for any reason any provision or provisions hereof
are determined to be invalid or contrary to applicable law, such invalidity or illegality shall not impair the operation of or
affect the remaining portions of this Subscription Agreement.

 

    	9

    	 

    

 

(f)          Paragraph
titles are for descriptive purposes only and shall not control or alter the meaning of this Subscription Agreement as set forth
in the text.

 

(g)          The
Purchaser understands and acknowledges that there may be multiple closings for this Offering.

 

18.         Omnibus
Signature Page. This Subscription Agreement is intended to be read and construed in conjunction with the Investor Rights Agreement
pertaining to the issuance by the Company of the shares of Common Stock and Warrants to subscribers pursuant to the Memorandum.
Accordingly, pursuant to the terms and conditions of this Subscription Agreement and such related agreements it is hereby agreed
that the execution by the Purchaser of this Subscription Agreement, in the place set forth herein, shall constitute agreement to
be bound by the terms and conditions hereof and the terms and conditions of the Investor Rights Agreement, with the same effect
as if each of such separate but related agreement were separately signed.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	10

    	 

    

 

LabStyle Innovations Corp.

 

OMNIBUS SIGNATURE PAGE TO THE

SUBSCRIPTION AGREEMENT AND INVESTOR RIGHTS
AGREEMENT

 

Subscriber hereby elects to subscribe
under the Subscription Agreement for a total of ______ Units at a price of $50,000 per Unit (NOTE: to be completed by subscriber)
and executes the Subscription Agreement.

 

Date (NOTE: To be completed by subscriber):
__________________

  

 

 

If the Purchaser is an INDIVIDUAL, and
if purchased as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY:

 

	 	 	 	 	 
	 	Print Name(s)	 	Social Security Number(s)	 
	 	 	 	 	 
	 	 	 	 	 
	 	Signature(s) of Subscriber(s)	 	Signature	 
	 	 	 	 	 
	 	 	 	 	 
	 	Date	 	Address	 

 

If the Purchaser is a PARTNERSHIP, CORPORATION,
LIMITED LIABILITY COMPANY or TRUST:

 

	 	 	 	 	 
	 	Name of Partnership,	 	Federal Taxpayer	 
	 	Corporation, Limited	 	Identification Number	 
	 	Liability Company or Trust	 	 	 

 

	 	By:	 	 	 	 
	 	 	Name:	 	State of Organization	 
	 	 	Title:	 	 	 

 

	 	 	 	 	 
	 	Date	 	Address	 

 

LABSTYLE INNOVATIONS
CORP.                                               SPENCER TRASK VENTURES, INC.

 

	By:	 	 	By:	 
	 	Authorized Officer	 	 	Authorized Officer

 

    	11Exhibit 10.5

 

 

INVESTOR RIGHTS AGREEMENT

 

This INVESTOR RIGHTS
AGREEMENT (this “Agreement”), dated as of this 27th day of October, 2011 is made by and among
LabStyle Innovations Corp., a Delaware corporation, (the “Company”), each founding stockholder of the Company
(as set forth on the signature pages hereto) who is signatory hereto (the “Founding Stockholders”), certain
affiliates (the “Placement Agent Parties”) of Spencer Trask Ventures, Inc. (the “Placement Agent”),
certain other shareholders of the Company (the “Other Stockholders”) who are signatory hereto, and each purchaser
of Common Stock (as defined below) who is or who becomes a signatory hereto in connection with the Offering (as defined below)
(each individually, a “Purchaser” and, collectively, the “Purchasers”).

 

WHEREAS, the
Founding Stockholders, the Placement Agent Parties and the Other Stockholders are the stockholders of the Company as of the date
hereof;

 

WHEREAS, the
entry into this Agreement by the parties hereto is a condition to closing of the Company’s offering (for which the Placement
Agent is acting as placement agent) of units consisting of up to an aggregate of 3,000,000 shares of the Common Stock and Warrants
to purchase a like number shares of Common Stock, in each case upon the terms set forth in the Company’s Confidential Private
Placement Memorandum, dated September 8, 2011, as the same may be amended or supplemented from time to time (the “Memorandum”);
and

 

WHEREAS, the
Company, the Placement Agent, the Founding Stockholders, the Placement Agent Parties, the Other Stockholders and the Purchasers
desire to provide for certain aspects of the conduct of the affairs of the Company, to regulate the transfer of equity securities
held by the Placement Agent Parties, the Other Stockholders, the Purchasers and the Founding Stockholders, and to define certain
of their rights and obligations with respect to the operation of the Company on the terms specifically set forth herein.

 

NOW, THEREFORE,
in consideration of the foregoing recitals, the agreements herein contained, and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

1.Certain Definitions.
As used in this Agreement, the following terms shall have the following respective meanings. All other capitalized terms are defined
elsewhere in this Agreement.

 

“Affiliate”
shall mean, with respect to any non-individual Purchaser, any person or entity that, directly or indirectly, controls or is controlled
by or is under common control with such Purchaser. As used in this definition “control” shall mean possession, directly
or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities, partnership
interests, and/or other equity or voting interests, by contract or otherwise).

 

“Board of
Directors” shall mean the Board of Directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

    	1

    	 

    
 

 

“Closing”
shall refer to any closing of the purchase and sale of units consisting of Common Stock and Warrants in the Offering.

 

“Commission”
shall mean the U.S. Securities and Exchange Commission, or any other federal agency at the time administering the Securities Act.

 

“Common Stock”
shall mean the common stock, par value $0.0001 per share, of the Company.

 

“Equity Securities”
shall mean shares of Common Stock, preferred stock, warrants, convertible notes and any other securities of the Company, either
in their own right or issued in exchange for, upon conversion or in substitution of, or otherwise in respect of such securities.

 

“Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder,
all as the same shall be in effect at the applicable time.

 

“Fair Market
Value” means with respect to any non-cash consideration, the fair market value of such non-cash consideration as determined
in good faith by the Board of Directors.

 

“Family Group”
shall mean, with respect to any Purchaser who is an individual, (i) such Purchaser’s spouse, former spouse, descendants (whether
natural or adopted), parents and their descendants and any spouse of the foregoing persons (collectively “relatives”),
or (ii) the trustee, fiduciary or personal representative of such Purchaser or any trust solely for the benefit of such Purchaser
and/or such Purchaser’s relatives.

 

“Final Closing”
shall refer to the final closing of the purchase and sale of units consisting of Common Stock and Warrants in the Offering.

 

“Governmental
Entity” means any federal, state, local or foreign court, legislative, executive or regulatory authority or agency.

 

“Group”
has the meaning assigned to such term in Section 13(d)(3) of the Exchange Act.

 

“Liquidity
Event” shall mean (i) the consummation of any merger, consolidation or similar business combination of the Company with
any other entity other than an affiliate of the Company and pursuant to which (A) the Company is not the surviving entity or (B)
the stockholders of the Company immediately before such transaction or series of related transactions own less than fifty (50%)
percent of the voting power of the surviving (or consolidated entity) immediately after such transaction, (ii) the consummation
of any sale of all or substantially all of the outstanding capital stock of the Company by the holders thereof (other than pursuant
to internal reorganizations), (iii) the consummation of any sale of all or substantially all of the assets of the Company, or (iv)
the consummation of any bona fide offer by a third party or Group of related parties, subject to customary
conditions and approved by the Board of Directors, to purchase all or substantially all of the outstanding securities of the Company
held by the Purchasers.

 

“Memorandum”
shall have the meaning set forth in the recitals hereto.

 

    	2

    	 

    
 

 

“Offering”
shall mean the Company’s minimum $500,000 and maximum $2,000,000 (with an over-allotment option of $1,000,000) offering of
units consisting of shares of Common Stock and Warrants as described in and made pursuant to the Memorandum.

 

“Permitted
Transferee” shall mean, with respect to each party hereto: (i) in the case of any individual, transferees who receive
shares pursuant to applicable laws of descent and distribution and members of such party’s Family Group and (ii) in the case
of a non-individual, such party’s Affiliates.

 

“Person”
means any individual, corporation, limited liability company, limited or general partnership, joint venture, association, joint-stock
company, trust, unincorporated organization, government or any agency or political subdivisions thereof or any Group comprised
of two or more of the foregoing.

 

“Pro Rata
Portion” means, for the purposes of Section 9 hereof, with respect to the Transferring Holder or any Tag-Along Participant,
with respect to any proposed Transfer, on the applicable Transfer date, the number of Equity Securities equal to the product of:
(i) the total number of Equity Securities to be Transferred to the proposed Transferee and (ii) the fraction determined
by dividing (A) the total number of Equity Securities owned by such Transferring Holder or Tag-Along Participant (as applicable)
as of such date plus the number of Equity Securities owned by all Affiliate Tag-Along Assignors of such Person by (B) the
total number of Equity Securities owned by the Transferring Holder and all Tag-Along Participants and their respective Affiliate
Tag-Along Assignors as of such date;

 

“Public Sale”
shall mean any sale of Equity Securities to the public pursuant to an offering registered under the Securities Act or pursuant
to the provisions of Rule 144 (or any similar rule or rules then in effect) under the Securities Act.

 

“Purchaser”
shall mean each individual or entity who executes the omnibus signature page to the Subscription Agreement and this Agreement;
provided, however, that the Company may reject any submission in whole or in part from any individual or entity
for any reason in the Company’s sole discretion.

 

“Qualified
IPO” shall mean: (i) the receipt of the Company of gross cash proceeds of at least $5,000,000 from the closing of a firmly
underwritten public offering of the Common Stock or (ii) the declaration of effectiveness of the Registration Statement by the
Commission.

 

“Registration
Statement” means a registration statement meeting the requirements set forth in Annex A attached hereto and covering
the resale by the Purchasers of their Equity Securities.

 

“Rule 144”
shall mean Rule 144 (or any other rule permitting public sale without registration) promulgated under the Securities Act.

 

“Securities
Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder, all
as the same shall be in effect at the time.

 

    	3

    	 

    
 

 

“Subscription
Agreement” shall mean the Subscription Agreement between the Company and each Purchaser that is executed in connection
with the Offering.

 

“Transfer”
shall mean any voluntary or involuntary, direct or indirect sale, transfer, conveyance, assignment, gift, donation, assignment,
pledge, hypothecation, delivery or other disposition by a Purchaser of Equity Securities, but shall not include any redemption
or repurchase of Equity Securities by the Company.

 

“Transferred”
shall mean any change in ownership by means of a Transfer.

 

“Transferee”
means any Person to whom any Purchaser or any Transferee thereof Transfers Equity Securities of the Company in accordance with
the terms hereof.

 

“Voting Securities”
means, at any time, shares of any class of Equity Securities of the Company, which are then entitled to vote generally in the election
of directors.

 

“Warrants”
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at a Closing in accordance with the Subscription
Agreement, which Warrants shall be exercisable immediately and have a term of exercise equal to 5 years.

 

“Warrant Shares”
means the shares of Common Stock issuable upon exercise of the Warrants.

 

2.Restrictive
Legend Requirements. Each certificate representing any shares of Equity Securities shall, except as otherwise provided in this
Section 2 or in Section 3 hereof, bear a legend substantially in the following form:

 

THIS SECURITY HAS NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED OR OTHERWISE SOLD
UNLESS IT HAS BEEN REGISTERED UNDER SUCH ACT AND ALL SUCH APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE ISSUER THAT APPLICABLE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS IS AVAILABLE.

 

IN ADDITION, THE TRANSFER OR SALE OF
THIS SECURITY IS SUBJECT TO THE TERMS OF THAT CERTAIN INVESTOR RIGHTS AGREEMENT, DATED AS OF ______________________, 2011, A COPY
OF WHICH IS ON FILE AT THE OFFICE OF THE COMPANY.

 

A certificate shall not bear the legend
set forth above (or any portion thereof) if, in the opinion of counsel reasonably satisfactory to the Company, the securities represented
thereby may be publicly sold without registration under the Securities Act and any applicable state securities laws.

 

    	4

    	 

    
 

 

3.General Restrictions
on Transfer.

 

(a)Any party hereto
may Transfer Equity Securities only (i) in a Public Sale or, subject to Section 3(d) hereof, to a Permitted Transferee and (ii)
pursuant to a valid exemption from registration under the Securities Act, provided that the party complies with this Section 3
and Sections 9 and 10 hereof.

 

(b)Except as expressly
provided for in this Agreement, all Transfers of Equity Securities by a party hereto or such party’s successors and assigns
shall be subject to the prior written approval of the Company, which approval shall not be unreasonably withheld, conditioned or
delayed (it being agreed that it shall not be unreasonable for the Company to refuse any purported Transfer that would cause the
Company to lose its exemption from registration under Section 12(g) of the Exchange Act or would otherwise violate any law, rule
or regulation or subject the Company or its stockholders (other than the Transferring Stockholder) to any material adverse consequence
(e.g., taxation, regulatory scrutiny, etc.). Prior to any proposed Transfer of any Equity Securities, the holder thereof shall
give written notice (a “Transfer Notice”) to the Company of its intention to effect such Transfer, and the Company
shall deliver a copy of such Transfer Notice to the Placement Agent within ten (10) Business Days of its receipt thereof. Each
such Transfer Notice shall describe the manner of the proposed Transfer, any consideration to be paid to the transferring party
and, if requested by the Company, shall be accompanied by an opinion of counsel reasonably satisfactory to the Company to the effect
that the proposed Transfer may be effected without registration under the Securities Act and any applicable state securities laws.
Each certificate representing any Equity Securities transferred as provided above shall bear the legends set forth in Section 2
hereof, except that such certificate shall not bear such legend (or any portion thereof) if: (i) such Transfer is in accordance
with the provisions of Rule 144 or (ii) the opinion of counsel referred to above is to the further effect that the transferee
and any subsequent transferee (other than an Affiliate of the Company) would be entitled to Transfer such securities in a Public
Sale without registration under the Securities Act. The restrictions provided for in this Section 3(b) shall not apply to securities
which are not required to bear the legend prescribed by Section 2 hereof in accordance with the provisions of that Section.

 

(c)If any Transfer
of Equity Securities is made or suffered by any Purchaser without the giving of a Transfer Notice required by this Agreement, such
purported Transfer shall be, to the extent permitted by law, void. Further, if any Equity Securities are the subject of a Transfer
not in accordance with the terms and conditions of this Agreement, such Transfer shall be, to the extent permitted by law, void
ab initio. In enforcing this provision, the Company may, to the extent permitted by law, hold and refuse
to transfer any Equity Securities or any certificate therefor tendered to it for transfer in addition to, and without prejudice
to, any and all other rights or remedies which may be available to it.

 

(d)In each case
of a Transfer to a Permitted Transferee, such Permitted Transferee shall agree, as a precondition to any such Transfer, to take
such shares subject to and to be fully bound by the terms of this Agreement with respect to shares Transferred by executing and
delivering a joinder to this Agreement (in a form provided by the Company) to the Company prior to the effectiveness of such Transfer
(unless such Transfer is pursuant to applicable laws of descent and distribution, in which case, such executed joinder shall be
delivered as soon as reasonably possible after such Transfer). Any Transfer to a Permitted Transferee not made in compliance with
this Section 3(d) shall be void ab initio.

 

    	5

    	 

    
 

 

(e)Notwithstanding
subsections (a) through (d) above and subsection (f) below, from the date hereof until the earlier of (i) the first anniversary
of the Final Closing and (ii) 180 days following the closing of a Qualified IPO (or, if permitted by the lead managing underwriter,
sooner), the Founding Stockholders shall not, without the Company’s and Placement Agent’s joint prior written consent
(which consent shall not be unreasonably withheld), conduct or effect a Transfer.

 

(f)Subject to the
terms and conditions of Annex A attached hereto, the restrictions provided for in subsections (a) through (d) above shall
expire upon the consummation of a Qualified IPO.

 

4.Right of Participation
in Proposed Issuances. 

 

(a) In
the event the Company, at any time after the date hereof and until the two (2) year anniversary of the Final Closing proposes to
issue, in a private placement transaction (a “Proposed Issuance”), any capital stock, options, warrants or other
rights to purchase any capital stock, or any securities convertible into or exchangeable for any capital stock (the “Dilutive
Securities”), each of the Purchasers shall have the right to subscribe for and purchase, on the same terms and
conditions as the Proposed Issuance, up to such amount of Dilutive Securities (the “Pro Rata Share”) as shall
equal (A) the sum of (a) the number of shares of Common Stock outstanding, on an “as-if converted” basis, immediately
prior to the issuance of the Dilutive Securities, plus (b) the number of shares of the Dilutive Securities proposed to be issued
multiplied by (c) Purchaser’s Ownership Percentage (as defined in this Section 4(a)), and minus (B) the number of shares
of Common Stock owned by such Purchaser, on an as-if converted basis with respect to such person, immediately prior to the issuance
of the Dilutive Securities. In addition, in the event that the Dilutive Securities are not fully subscribed
by all Purchasers (the “Unsubscribed Dilutive Securities”), each of Purchasers shall have the right to subscribe
for and purchase the Unsubscribed Dilutive Securities on a pro-rata basis. As used herein, any reference to capital stock on an
“as-if converted” basis shall mean all shares of Common Stock outstanding, plus shares of Common Stock issuable upon
conversion or exercise of outstanding convertible debt, warrants and/or other equity securities. The Purchaser’s “Ownership
Percentage” shall be equal to the number of shares of Common Stock owned by such Purchaser, on an as-if converted basis,
immediately prior to the issuance of the Dilutive Securities, divided by the number of shares of Common Stock of the Company outstanding,
on an as-if converted basis, immediately prior to the issuance of the Dilutive Securities. Dilutive Securities shall not
include issuances of securities by the Company: (i) in connection with a stock dividend or upon any subdivision of shares
of the Company’s capital stock in the event that the securities issued pursuant to such stock dividend or subdivision are
limited to additional shares of the Company’s capital stock; (ii) pursuant to subscriptions, warrants, options, convertible
securities, convertible notes or other rights that are disclosed in the Memorandum, (iii) pursuant to the issuance of options,
or upon the exercise thereof, under any existing stock option plan or stock purchase plan adopted by the Company, or any similar
plan that is later approved by the Board of Directors, not to exceed twenty (20%) percent of the Company’s capital stock
on an as-if converted basis after giving effect to the Offering; (iv) pursuant to the exercise of warrants issued to the Placement
Agent or its designees in connection with the Offering or the shares issuable upon exercise thereof; (v) in connection with the
acquisition of any other corporation by merger, purchase of another entity’s capital stock or assets or a similar transaction
that has been approved by the Board of Directors; (vi) in connection with equity issuances to strategic investors or commercial
or collaborative partners (provided the primary purpose of such issuance is not the raising of capital), or financial institutions,
lessors or vendors that are unrelated third parties in connection with a bona fide provision of credit or
services to the Company, equipment financing or similar transactions approved by the Board of Directors; (vii) in connection with
a Liquidity Event; and (viii) in connection with a Qualified IPO.

 

    	6

    	 

    
 

 

(b)At
least ten (10) Business Days prior to any Proposed Issuance of Dilutive Securities, the Company shall give written notice to each
Purchaser (the “PR Notice”). The PR Notice shall state: (i) the date of the Proposed Issuance; (ii) the terms
of the Proposed Issuance, including price and date that payment for the Dilutive Securities must be made; (iii) the number of
Dilutive Securities to be issued and the number of Dilutive Securities which such Purchaser is entitled to purchase; and (iv)
the date (which shall be at least ten (10) Business Days following the effective date of such PR Notice) by which such Purchaser
is required to accept the Company’s offer to purchase his respective portion of the Dilutive Securities (the “Acceptance
Date”). If, subsequent to the Company giving the PR Notice to each Purchaser, the terms and conditions of the Proposed
Issuances are changed, modified or amended, the Company shall provide a new PR Notice to each Purchaser. Each Purchaser shall
have the right to purchase its Pro Rata Share of the Dilutive Securities at the price and terms set forth in the new PR Notice.
The Placement Agent shall assist the Company in providing PR Notices to and communicating with Purchasers in connection with the
matters described in this Section 4.

 

(c)Each
Purchaser may accept the Company’s offer to purchase its Pro Rata Share of the Dilutive Securities (and, if so indicated
in writing by the Purchaser, its proportionate share of any Unsubscribed Dilutive Securities) at the
price and terms set forth in the PR Notice by sending written notice to the Company (the “Acceptance Notice”)
at any time prior to the Acceptance Date. The Purchaser’s failure to send the Acceptance Notice by the Acceptance Date shall
constitute a rejection of the Company’s offer to purchase such Purchaser’s respective portion of the Dilutive Securities
or Unsubscribed Dilutive Securities. Each Purchaser shall pay for the full amount for the Dilutive
Securities or Unsubscribed for Dilutive Securities (as the case may be) purchased on or before
the date specified in the PR Notice. The Company shall issue to such Purchaser certificates representing the Dilutive Securities
or Unsubscribed for Dilutive Securities purchased within five (5) Business Days of the closing
of their sale. 

 

(d)The Company
shall be free at any time prior to ninety (90) days after the date of the Acceptance Date to offer and sell to any third party
or parties the number of such securities not purchased by Purchasers at a price and on payment terms no less favorable to the Company
than those specified in the PR Notice. However, if such third party sale or sales are not consummated within such 90 day period,
the Company shall not sell such securities as shall not have been purchased within such period without again complying with the
provisions of this Section 4.

 

(e)Each
Purchaser’s right of participation in a Proposed Issuance set forth in this Section 4 may not be assigned or transferred,
except that (i) such right is assignable by each Purchaser to any wholly owned subsidiary or parent of, or to any corporation
or entity that is, within the meaning of the Securities Act, controlling, controlled by or under common control with, any such
Purchaser, and (ii) such right is assignable between and among any of Purchasers.

    	7

    	 

    
 

 

(f)Each Purchaser’s
right of participation in a Proposed Issuance set forth in this Section 4 may be waived (either generally or in a particular instance,
either retroactively or prospectively and either for a specific period of time or indefinitely), amended, discharged or terminated
by the written consent of such Purchaser.

 

(g)In the event
that a Purchaser fails to purchase its full Pro Rata Share of Dilutive Securities in any Proposed Issuance, then such Purchaser
shall not be entitled to any further rights thereafter under this Section 4 for such Proposed Issuance or any closing thereof.
Notwithstanding the foregoing, a Purchaser shall have the right to participate in subsequent Proposed Issuances pursuant to this
Section 4.

 

5.Placement
Agent Director Rights. 

 

(a)Each of the
Purchasers acknowledges and agrees that, for a period of two (2) years from the first Closing of the Offering, the Placement Agent
will be entitled to nominate for election to the Board of Directors one (1) director (the “Placement Agent Director”),
which shall initially be Adam Stern. The Company shall take all necessary and desirable actions within its control, including,
without limitation, calling stockholders’ and directors’ meetings, and each Founding Stockholder, Placement Agent Party,
Other Stockholder and Purchaser shall vote the Equity Securities owned by him, her or it, or over which he, she or it has voting
control at any stockholders’ meeting or execute proxies, consents or other documents or agreements in order to act by written
consent with respect to such Equity Securities, and shall take all other reasonably necessary actions within such person’s
control (whether in such person’s capacity as a stockholder, director, member of a committee of the Board of Directors or
officer of the Company or otherwise, and including attendance at the Board of Directors’ and/or stockholders’ meetings
in person or by proxy for purposes of attaining a quorum and execution of written consents in lieu of meetings) in order to cause:

 

(i)                
the election to the Board of Directors of the Placement Agent Director until his/her successor has been designated as provided
for herein, so approved, duly elected and qualified;

 

(ii)              
the removal of the Placement Agent Director (with or without cause) at the written request of the Placement Agent or as
otherwise provided for in the Company’s Certificate of Incorporation or Bylaws; and

 

(iii)            
the election to the Board of Directors of an individual designated by the Placement Agent to fill any vacancy created in
the event that the Placement Agent Director for any reason ceases to serve as a member of the Board of Directors during such member’s
term of office.

 

(b)In the event
that the Placement Agent Director ceases to serve as a member of the Board of Directors for any reason, the resulting vacancy shall
be filled by a person designated in writing by the Placement Agent. The Founding Stockholders, the Other Stockholders and Purchasers
agree to vote and take all other action in order to ensure that such designated replacement director shall be elected to the Board
of Directors.

 

    	8

    	 

    
 

 

(c)Any designee
elected pursuant to this Section 5 shall hold office until his or her successor shall have been duly designated, elected and qualified
or he or she shall have been earlier removed from such office pursuant to the terms hereof.

 

(d)In the
event that Adam Stern is not then serving as the Placement Agent Director, the Company shall provide the Placement Agent with at
least fifteen (15) Business Days’ prior written notice of any intended mailing of a notice to stockholders for a meeting
at which directors are to be elected. The Placement agent shall give written notice to the Company, no later than ten (10) Business
Days prior to such mailing, of the persons designated pursuant to Section 5(a) hereto as nominees for election as directors. The
Company agrees to nominate and recommend for election as the Placement Agent Director only the individual(s) designated, or to
be designated, pursuant to Section 5(a). If the Placement Agent shall fail to give notice to the Company as provided above, it
shall be deemed that the designee then serving as a director shall be the designees for reelection.

 

(e)The Placement
Agent Director shall be entitled to the same indemnification and director compensation (if any) as any other director of the Company
and shall be subject to removal on the same terms as any other director of the Company.

 

6.Intentionally
Omitted.

 

7.Intentionally Omitted. 

 

8.Information.
Until the earlier of a Qualified IPO or the fifth (5th) anniversary of the Closing, the Company shall deliver to
the Placement Agent and the Purchasers (i) annual audited financial statements setting forth fairly the financial position
of the Company, (ii) quarterly unaudited financial statements including both a balance sheet and statement of income (with
year over year quarterly comparisons), (iii) a quarterly report of the progress and status of the Company and (iv) an annual report
setting forth clearly the financial position and outlook of the Company; provided, that such report need not contain
information reasonably deemed confidential by the Board of Directors. In addition the Company shall deliver to the Placement Agent
a copy of a list of its stockholders as and when so requested; provided, that such information shall only be used
in connection with the Company.

 

9.Tag Along
Rights.

 

(a)In the event
of a proposed Transfer (other than a Transfer to a Permitted Transferee, to which this Section 9 shall not apply) of Equity Securities
by any of David Weintraub, Strategic Models, LLC (or its Affiliates, including Oren Fuerst), Shilo Ben Zeev, Meir Plevinski or
Dov Oppenheim, each a Founding Stockholder (in this context, a “Transferring Holder”), each party hereto (other
than the Transferring Holder) shall have the right to participate in such Transfer on the same terms and conditions and for the
same per Equity Security consideration as the Transferring Holder in the Transfer in the manner set forth in this Section 9. Prior
to any such Transfer, the Transferring Holder shall deliver to the Company the Transfer Notice, which the Company will forward
to the other parties hereto (other than the Transferring Holder) (such parties, in this context, the “Tag-Along Participants”)
within 5 days of receipt thereof, which notice shall state (i) the name of the proposed Transferee, (ii) the number of shares of
Equity Securities proposed to be Transferred (the “Transferred Securities”) and the percentage (the “Tag
Percentage”) that such number of shares of Equity Securities constitute of the total number of shares of Equity Securities
owned by such Transferring Holder, (iii) the proposed purchase price therefore, including a description of any non-cash consideration
sufficiently detailed to permit the determination of the Fair Market Value thereof, and (iv) the other material terms and conditions
of the proposed transfer, including the proposed transfer date (which date may not be less than 35 days after delivery to the Tag-Along
Participants of the Transfer Notice). The Placement Agent shall assist the Company in providing Transfer
Notices to and communicating with the Placement Agent Parties, the Other Stockholders and the Purchasers in connection with the
matters described in this Section 9. Such Transfer Notice shall be accompanied by a written offer from the proposed Transferee
to purchase the Transferred Securities, which offer may be conditioned upon the consummation of the sale by the Transferring Holder,
or the most recent drafts of the purchase and sale documentation between the Transferring Holder and the Transferee which shall
make provision for the participation of the Tag-Along Participants in such sale consistent with this Section 9.

 

    	9

    	 

    
 

 

(b)Each Tag-Along
Participant may elect to participate in the proposed Transfer to the proposed Transferee identified in the Transfer Notice by giving
written notice to the Company and to the Transferring Holder within the 15 day period after the delivery of the Transfer Notice
to such Tag-Along Participant, which notice shall state that such Tag-Along Participant elects to exercise its rights of tag-along
under this Section 9 and shall state the maximum number of shares sought to be Transferred (which number may not exceed the product
of (i) all such Shares owned by such Tag-Along Participant plus the number of Shares owned by any Affiliate Tag-Along Assignor
of such Tag-Along Participant, multiplied by (ii) the Tag Percentage). As used in this Agreement, the term “Affiliate
Tag-Along Assignor” with respect to any party, shall mean an Affiliate of such party or, in the case of any member of
a Group, any other member of such Group that, in each case, shall have waived, by means of written notice to the Company and the
Transferring Holder, its tag-along rights pursuant to this Section 9 with respect to the applicable Transfer in favor of such Purchaser.
Each Tag-Along Participant shall be deemed to have waived its right of tag-along with respect to the Transferred Securities hereunder
if it fails to give notice within the prescribed time period. The proposed Transferee of Transferred Securities will not be obligated
to purchase a number of Equity Securities exceeding that set forth in the Transfer Notice, and in the event such Transferee elects
to purchase less than all of the additional Equity Securities sought to be Transferred by the Tag-Along Participants, the number
of Equity Securities to be Transferred by the Transferring Holder and each such Tag-Along Participant shall be reduced so that
each such Purchaser is entitled to sell its Pro Rata Portion of the number of Equity Securities the proposed Transferee elects
to purchase (which in no event may be less than the number of Transferred Securities set forth in the Transfer Notice).

 

(c)Each Tag-Along
Participant, if it is exercising its tag-along rights hereunder, shall deliver to the Transferring Holder at the closing of the
Transfer of the Transferring Holder's Transferred Securities to the Transferee certificates representing the Transferred Securities
to be Transferred by such holder, duly endorsed for transfer or accompanied by stock powers duly executed, in either case executed
in blank or in favor of the applicable purchaser against payment of the aggregate purchase price therefor by wire transfer of immediately
available funds. Each Purchaser participating in a sale pursuant to this Section 9 shall receive consideration in the same form
and per share amount after deduction of such Purchaser’s proportionate share of the related expenses. Each party hereto participating
in a sale pursuant to this Section 9 shall agree to make or agree to the same customary representations, covenants, indemnities
and agreements as the Transferring Holder so long as they are made severally and not jointly and the liabilities thereunder are
borne on a pro rata basis based on the consideration to be received by each party hereto; provided,
that any general indemnity given by the Transferring Holder, applicable to liabilities not specific to the Transferring Holder,
to the Transferee in connection with such sale shall be apportioned among the Tag-Along Participants participating in a sale pursuant
to this Section 9 according to the consideration received by each such party and shall not exceed such party’s net proceeds
from the sale; and provided, further, that any representation relating specifically to a party and/or
its ownership of the Equity Securities to be Transferred shall be made only by that Tag-Along Participant. The fees and expenses
incurred in connection with a sale under this Section 9 and for the benefit of all Tag-Along Participants (it being understood
that costs incurred by or on behalf of a particular Tag-Along Participant for his, her or its sole benefit will not be considered
to be for the benefit of all parties), to the extent not paid or reimbursed by the Company or the Transferee or acquiring Person,
shall be shared by all the Tag-Along Participants on a pro rata basis, based on the consideration received by each Tag-Along Participant
in respect of its Equity Securities to be Transferred; provided that no Tag-Along Participant shall be obligated to make any out-of-pocket
expenditure prior to the consummation of the transaction consummated pursuant to this Section 9 (excluding de minimis expenditures).
The proposed Transfer date may be extended beyond the date described in the Transfer Notice to the extent necessary to obtain required
approvals of governmental or administrative entities and other required approvals, and the Company and the Tag-Along Participants
shall use their respective commercially reasonable efforts to obtain such approvals.

 

    	10

    	 

    
 

 

(d)If the Transferring
Holder sells or otherwise Transfers to the Transferee any of its Equity Securities in breach of this Section 9, then each Tag-Along
Participant shall have the right to sell to each Transferring Holder, and each Transferring Holder undertakes to purchase from
each Tag-Along Participant, the number of Equity Securities that such Tag-Along Participant would have had the right to sell to
the Transferee pursuant to this Section 9, for a per Equity Security amount and form of consideration and upon the terms and conditions
on which the Transferee bought such Equity Securities from the Transferring Holder, but without any indemnity being granted by
any Tag-Along Participant to the Transferring Holder; provided that nothing contained in this Section 9(d) shall preclude
any Purchaser from seeking alternative remedies against any such Transferring Holder as a result of its breach of this Section
9.

 

(e)The provisions
of this Section 9 shall expire upon the consummation of a Qualified IPO.

 

10.Drag Along
Right.

 

(a) If one or more
parties or Groups of parties signatory hereto propose to Transfer all of their Equity Securities, representing more than 50% of
the Voting Securities of the Company, and, for so long as such a Transfer requires any approval hereunder, such Transfer has been
so approved, then if the party(s) Transferring such Equity Securities (the “Section 10 Transferring Holder(s)”)
exercise their drag-along rights set forth in this Section 10, each other party hereto (in this context, each, a “Selling
Holder”) shall be required to sell all of the Equity Securities held by it of the same type as any of the Equity Securities
to be Transferred.

 

    	11

    	 

    
 

 

(b)The consideration
to be received by a Selling Holder shall be the same form and amount of consideration per security to be received by the Section
10 Transferring Holder(s), and the terms and conditions of such sale shall be the same as those upon which the Section 10 Transferring
Holder(s) sells its Equity Securities. In connection with the transaction contemplated by this Section 10 (the “Drag Transaction”),
each Selling Holder will agree to make or agree to the same customary representations, covenants, indemnities and agreements as
the Section 10 Transferring Holder(s) so long as they are made severally and not jointly and the liabilities thereunder are borne
on a pro rata basis based on the consideration to be received by each Selling Holder; provided, that (i) any general indemnity
given to the purchaser by the Selling Holder(s), applicable to liabilities not specific to the Selling Holder, in connection with
such sale shall be apportioned among the to the Selling Holders to the purchaser according to the consideration received by each
Selling Holder and shall not exceed such Selling Holder’s net proceeds from the sale, (ii) that any representation relating
specifically to a Selling Holder and/or its Equity Securities shall be made only by that Selling Holder, and (iii) in no event
shall any Selling Holder be obligated to agree to any non-competition covenant or other similar agreement as a condition of participating
in such Transfer.

 

(c)The fees and
expenses incurred in connection with a sale under this Section 10 and for the benefit of all Section 10 Transferring Holders and
Selling Holders (it being understood that costs incurred by or on behalf of a particular Selling Holder for his, her or its sole
benefit will not be considered to be for the benefit of all Selling Holders), to the extent not paid or reimbursed by the Company
or the Transferee or acquiring Person, shall be shared by all the Section 10 Transferring Holders on a pro rata basis, based on
the consideration received by each Section 10 Transferring Holders in respect of its Equity Securities.  

 

(d)The Section
10 Transferring Holder(s) shall provide written notice (the “Drag Along Notice”) to each other Selling Holders
of any proposed Drag Transaction as soon as practicable following its election to exercise the rights provided in Section 10(a).
The Drag Along Notice shall set forth the consideration to be paid by the purchaser for the securities, the identity of the purchaser
and the material terms of the Drag Transaction.

 

(e)If any holders
of the Equity Securities of any class are given an option as to the form and amount of consideration to be received in the Drag
Transaction, all holders of the Equity Securities of such class must be given the same option.

 

(f)Any Selling
Holders whose assets (“Plan Assets”) constitute assets of one or more employee benefit plans and are subject
to Part IV of Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), shall not
be obligated to sell to any Person to whom the sale of any Equity Securities would constitute a non-exempt “prohibited transaction”
within the meaning of ERISA or the Internal Revenue Code of 1986, as amended; provided, however, that
if so requested by the Section 10 Transferring Holder(s): (i) such Selling Holder shall have taken commercially reasonable efforts
to (x) structure its sale of Equity Securities so as not to constitute a non-exempt “prohibited transaction” or (y)
obtain a ruling from the U.S. Department of Labor to the effect that such sale (as originally proposed or as restructured pursuant
to clause (i)(x)) does not constitute a non-exempt “prohibited transaction” and (ii) such Selling Holder shall have
delivered an opinion of counsel (which opinion and counsel are reasonably satisfactory to the Section 10 Transferring Holder(s))
to the effect that such sale (as originally proposed or as restructured pursuant to clause (i)(x)) would constitute a non-exempt
“prohibited transaction.”

 

    	12

    	 

    
 

 

(g)Upon
the consummation of the Drag Transaction and delivery by any Selling Holder of the duly endorsed certificate or certificates representing
the Equity Securities held by such Selling Holder to be sold together with a stock power duly executed in blank, the acquiring
Person shall remit directly to such Selling Holder, by wire transfer of immediately available funds, the consideration for the
securities sold pursuant thereto.

 

(h)The provisions
of this Section 10 shall expire upon the consummation of a Qualified IPO.

 

11.Intentionally
Omitted.

 

12.Registration
Rights. The Purchasers are granted the registration rights described on Annex A attached hereto and incorporated herein
by reference.

 

13.Termination.
This Agreement shall automatically terminate upon the happening of any of the following events (provided, however,
that Annex A and the obligations set forth in Sections 4 and 5 hereof shall survive any such automatic termination):

 

(a)the bankruptcy,
receivership or dissolution of the Company;

 

(b)the voluntary
agreement by and among the Company, the Placement Agent and Purchasers holding more than fifty (50%) percent of the total number
of Equity Securities held by all Purchasers on the termination date;

 

(c) a Qualified
IPO; or

 

(d)the consummation
of a Liquidity Event.

 

14.Governing
Law; Arbitration of Disputes. This Agreement shall be governed by and construed in accordance with the laws of the State of
New York applicable to contracts entered into and to be performed wholly within such State, and without regard to the conflicts
of laws principals thereof. Each of the parties hereto agrees that any dispute arising out of or in connection with this Agreement
shall be resolved as outlined in this Section 14. Any parties to any such dispute shall first attempt in good faith to resolve
such dispute. If, notwithstanding such efforts, such dispute is not resolved within thirty (30) days from the date written notice
thereof is delivered by a party hereto, such dispute shall be settled by arbitration by, and in accordance with, the then existing
rules of the American Arbitration Association (“AAA”). Hearings with regard to such dispute shall be held at
the offices of the AAA in the City and County of New York and judgment upon any award rendered pursuant to this Section 14 may
be entered in any court of competent jurisdiction. Any award rendered pursuant to the terms and conditions set forth herein shall
be final and binding. Any such arbitration shall be had before a single arbitrator designated in accordance with the rules of the
AAA. Any party to the arbitration shall be entitled to costs and expenses and reasonable attorney’s fees in the event it
prevails in any claims, actions, awards or judgment under this Agreement.

 

    	13

    	 

    
 

 

15.Miscellaneous.

 

(a)Entire Agreement.
This Agreement and the agreements contemplated by the Memorandum with respect to the Offering constitute the entire agreement of
the parties regarding the subject matter hereof, and supersede all prior agreements and understandings, both written and oral,
among the parties, or any of them, with respect to the subject matter hereof.

 

(b)References
and Interpretation. All references to “Sections” contained herein are, unless specifically indicated otherwise,
references to sections of this Agreement. Whenever herein the singular number is used, the same shall include the plural where
appropriate, and words of any gender shall include each other gender where appropriate. The captions, headings and arrangements
used in this Agreement are for convenience only and do not in any way affect, limit, amplify or modify the terms and provisions
hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent,
and no rules of strict construction will be applied against any party.

 

(c)Notices.
Any consent, approval, notice, request or demand required or permitted by this Agreement must be in writing and shall be deemed
to have been given when actually received by the party to whom notice is sent and shall be delivered either (i) personally or (ii)
by registered or certified mail, postage prepaid, (iii) by recognized overnight courier or (iv) by facsimile transmission, addressed
to the parties as follows:

 

in the case of the
Company to:

 

LabStyle Innovations Corp.

c/o Strategic Models, LLC

350 Fifth Avenue, 59th Floor

New York, NY 10018

Attention: Oren Fuerst

Fax Number: (646) 349-3180

 

with a copy (which shall not constitute notice)
to: 

 

Ellenoff Grossman
& Schole LLP

150 East 42nd Street, 11th Floor

New York, NY 10017

Attention: Lawrence A. Rosenbloom, Esq.

Fax Number: (646) 895-7204

 

    	14

    	 

    
 

 

in the case of the Placement Agent, the Placement
Agent Parties, and the Other Stockholders to:

Spencer Trask Ventures, Inc.

750 Third Avenue, 11th Floor

New York, NY 10017

Attention: John Heidenreich and Adam Stern

Fax Number: (212) 829-4405

 

with a copy (which shall not constitute notice)
to: 

 

Littman Krooks LLP

655 Third Avenue, 20th Floor

New York, NY 10017

Attention: Steven D. Uslaner, Esq.

Fax Number: (212) 490-2990

 

in the case of any Purchaser
or Founding Stockholder, at the address and/or fax number for such Purchaser or Founding Stockholder as set forth in the records
of the Company.

 

Any party may change
their address for notifications by providing proper notice to the other parties.

 

(b)Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the Purchasers and the Company and their
respective successors, heirs, personal representatives and assigns, including, but not limited to, any transferee of Equity Securities
as permitted hereunder.

 

(c)Invalid Provisions.
If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws effective during
the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as-if such
illegal, invalid or unenforceable provision had never comprised a part of this Agreement, and the remaining provisions of this
Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or
by its severance from this Agreement. Furthermore, in lieu of each such illegal, invalid or unenforceable provision there shall
be deemed added automatically as a part of this Agreement a provision, as similar in terms to such illegal, invalid or unenforceable
provision as may be possible, that is legal, valid and enforceable.

 

(d)Amendments.
This Agreement may be amended at any time and from time to time, in whole or in part by an instrument in writing setting forth
the particulars of such amendment duly executed by the Company, the Placement Agent and the Purchasers holding more than 50% of
the total number of shares of Equity Securities held by all Purchasers at the time of such amendment.

 

    	15

    	 

    
 

 

(e)Multiple
Counterparts; Execution. This Agreement may be executed in a number of counterparts (including via the omnibus signature page
described in Section 16 hereof), each of which for all purposes is to be deemed an original, and all of which constitute collectively
one Agreement; but in making proof of this Agreement, it shall not be necessary to produce or account for more than one such counterpart.
It is not necessary that each Purchaser execute the same counterpart, so long as identical counterparts are executed by the Company
and each Purchaser. In the event that any counterpart is delivered by facsimile transmission or by an e-mail which contains a portable
document format (.pdf) file of an executed signature page, such counterpart signature page shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page
were an original thereof.

 

(f)Enforcement.
It is specifically agreed and understood that monetary damages will not adequately compensate the breach of this Agreement
and this Agreement shall therefore be specifically enforceable, and any breach or threatened breach of this Agreement shall be
the proper subject of a temporary or permanent injunction or restraining order in accordance with the rules for such actions promulgated
by the AAA. Further, each party hereto and their successors, heirs, representatives and assigns waive any claim or defense that
there is an adequate remedy at law for such breach or threatened breach.

 

(i)Severability.
It is expressly understood and agreed that, to the extent permitted by applicable law, the provisions hereof are each severable
from the rest of this Agreement and shall be fully effective, operative, and enforceable even though the remainder of any part
of this Agreement shall be held to be invalid or unenforceable under any circumstances.

 

16.Omnibus Signature
Page. This Agreement is intended to be read and construed in conjunction with the Subscription Agreement pertaining to the
issuance by the Company of the shares of Common Stock to the Purchasers pursuant to the Memorandum. Accordingly, pursuant to the
terms and conditions of this Agreement and such related agreements it is hereby agreed that the execution by Purchasers of the
Subscription Agreement, in the place set forth therein, shall constitute their agreement to be bound by the terms and conditions
hereof and the terms and conditions of the Subscription Agreement, with the same effect as if each of such separate but related
agreements were separately signed.

 

 

 

[Signature Pages Follow]

 

    	16

    	 

    
 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement on the date first written above and binding on each party from and after the date
such party executes this Agreement or a counterpart hereof.

 

COMPANY:

 

LABSTYLE INNOVATIONS CORP.

 

 

 

By: /s/ Oren Fuerst________________________

Name: Oren Fuerst

Title: Chief Executive Officer

 

PLACEMENT AGENT:

 

SPENCER
TRASK VENTURES, INC.

 

 

 

By: /s/ John Heidenreich____________________

Name: John Heidenreich

Title: President

 

FOUNDING STOCKHOLDERS:

 

 

 

/s/ David Weintraub_______________________

David Weintraub

 

STRATEGIC
MODELS, LLC

 

 

 

By:  /s/ Oren Fuerst________________________

Name: Oren Fuerst

Title: Managing Member

 

 

 

/s/ Meir Plevinski__________________________

Meir Plevinski

 

 

[Signature Pages Continue]

 

    	17

    	 

    
 

 

/s/ Dov Oppenheim____________________

Dov Oppenheim

 

 

 

/s/ Shilo BenZeev_____________________

Shilo BenZeev

 

 

 

/s/ Soshana Friedman __________________

Soshana Friedman

 

 

 

/s/ Irena Cohen / /s/ Eyal Cohen__________

Irena and Eyal Cohen, JTWRS

 

 

 

/s/ Yaniv Michaeli_____________________

Yaniv Michaeli

 

 

 

[End of Signatures Pages to Investor Rights
Agreement]

 

    	18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]